Inhibition of insulin‐like growth factor 2 mRNA‐binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics

Although colorectal cancer (CRC) treatment has seen a remarkable improvement in the recent years, many patients will develop metastasis due to the resistance of cancer cells to chemotherapeutics. Targeting mechanisms driving the resistance of CRC cells to treatment would significantly reduce cases o...

Descripción completa

Detalles Bibliográficos
Autores principales: Betson, Nicole, Hajahmed, Mohammed, Gebretsadek, Tsige, Ndebele, Kenneth, Ahmad, H. Anwar, Tchounwou, Paul B., Spiegelman, Vladimir S., Noubissi, Felicite K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721091/
https://www.ncbi.nlm.nih.gov/pubmed/36479210
http://dx.doi.org/10.1096/fba.2021-00069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721091/
https://www.ncbi.nlm.nih.gov/pubmed/36479210
http://dx.doi.org/10.1096/fba.2021-00069

Ejemplares similares